Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Organoids Market?

The expansion of the organoids market has been significant in recent past, forecasted to rise from $3.98 billion in 2024 to $4.82 billion in 2025, with a compound annual growth rate (CAGR) of 21.0%. The historical growth of this market is tied to advancements in biomedical research, the necessity for drug discovery and development, the demand for disease modeling, the inclination towards personalized medicine, and support from regulatory bodies.

The market for organoids is predicted to experience significant expansion over the coming years, reaching a value of $10.76 billion by 2029, growing at the compound annual rate of 22.2%. The forecasted growth is linked to the rising occurrence of long-term illnesses, evolution in genome modification methods, an increase in stem cell studies, the formation of partnerships and collaborations, as well as efforts towards clinical translation. Key trends in this forecast period take into account their use in regenerative medicine, techniques for in vivo imaging, collaborations forming multi-organoid systems, considerations of ethics and legality, and efforts towards market commercialization and expansion.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10787&type=smp

What Growth-Enabling Forces Are Impacting The Organoids Market?

The projected growth of the organoid market can be attributed to the escalating incidence and prevalence of both chronic and infectious diseases. Chronic diseases are typically conditions that persist for over a year, necessitating ongoing medical intervention. Organoids are instrumental in the study of these diseases and potential treatments because they provide reliable and immediate insights into pathogen biology and drug screening. This means that an increasing rate of chronic and infectious diseases will likely bolster the organoid market. For instance, the National Health Service, a publicly-funded healthcare system from the UK, reported in June 2024 that 3,615,330 people, registered with a GP, were diagnosed with non-diabetic hyperglycemia or pre-diabetes. This was an 18% increase from the 3,065,825 registered cases in 2022. As a result, the growing prevalence of chronic conditions is anticipated to stimulate the organoids market.

How Does The Organoids Market Differ By Segment?

The organoidsmarket covered in this report is segmented –

1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid

2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells

3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications

4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users

Subsegments:

1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids; Primary Liver Cell-Derived Organoids; Liver Tumor Organoids

2) By Colorectal Organoid: Colonic Organoids; Rectal Organoids; Colorectal Cancer Organoids

3) By Intestinal Organoid: Small Intestinal Organoids; Enteroid Organoids; Intestinal Stem Cell-Derived Organoids

4) By Other Organoid: Pancreatic Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Others

What New Opportunities Are Emerging From Trends In The Organoids Market?

Technological progress is an emerging trend in the organoid market with leading companies releasing new organoid technologies to maintain their market leadership. An example of this happened in March 2023, when the Netherlands-based MIMETAS, known for developing human tissue and disease models, introduced a new kind of adult stem cell (ASC)-derived tubular organoids within the OrganoReady product line. This novel organoid relies on state-of-the-art and pioneering technology to study mechanistic toxicology and drug-induced organ damage. The organoids are engineered as perfused 3D tubular structures with access points on both the apical and basal sides utilizing the OrganoPlate, a patented microfluidic platform.

Who Are The Most Influential Companies In The Organoids Market?

Major companies operating in the organoids market include Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sàrl

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Which Region Is Leading Innovation In The Organoids Market?

North America was the largest region in the organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10787&type=smp

Browse Through More Reports Similar to the Global Organoids Market 2025, By The Business Research Company

Cell And Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Cell Cultures Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model